2001
Release time:
2021-05-11
With an investment of RMB 130 million, Jilin Jiuxin Pharmaceutical Co., Ltd. was established. The company’s facility covers an area of 150,000 square meters and holds 39 nationally approved drug registration numbers, 8 health‑food registration numbers, and 3 food registration numbers, making it one of the few enterprises in the industry capable of simultaneously manufacturing all three categories. Its core business focuses on the production of traditional Chinese medicines, health foods, and food products. Key pharmaceutical products include Weilexin Capsules, Qingre Anchuang Pills, Pharyngitis Tablets, Tongmai Granules, Suguanning, and Yishenling, which together command a national market share exceeding 10%. Among its best‑selling health foods, JunTai Capsules achieve annual sales of RMB 600 million.
With an investment of RMB 130 million, Jilin Jiuxin Pharmaceutical Co., Ltd. was established, operating on a 150,000-square-meter campus. The company holds 39 nationally approved drug registration numbers, 8 health‑food registration numbers, and 3 food registration numbers, making it one of the few enterprises in the industry capable of simultaneously manufacturing all three categories. Its core business focuses on the production of traditional Chinese medicines, health foods, and food products. Key pharmaceutical products include Weilexin Capsules, Qingre Anchuang Pills, Pharyngitis Tablets, Tongmai Granules, Suguanning, and Yishenling, collectively commanding over 10% of the national market share. Among its health‑food offerings, JunTai Capsules achieve annual sales of RMB 600 million.
Latest Updates
In the golden autumn season, the fragrance of ripe fruits fills the air. On the morning of August 23, Jiuxin Group’s “Shining with Jiuxin, Embarking on a New Journey” 2025 reward ceremony for employees’ children who have been admitted to higher education was solemnly held in the grand conference room on the first floor of Jiuxin Daily Chemical. Company leaders, along with 64 employees and their children and parents, gathered together to share the joy of these students’ academic success and to witness this heartwarming moment brimming with hope.
Manting’s innovative bio‑based anti‑dandruff technology has been awarded the Science and Technology Progress Award by the China National Light Industry Council. Manting President Chen Guoqing attended the award ceremony and accepted the prize on behalf of the company.
In this season of sowing hope and painting a vibrant future, Jiuxin Group celebrated the joyous occasion of 48 employees’ children achieving academic success. On the afternoon of August 20, the group solemnly held the “Youth in Its Prime, Setting Sail on a New Journey” 2024 Scholarship Ceremony for Employees’ Children.